ヒトのプリインプラント胚および多能細胞における内在レトロウイルスの再活性化
Edward J Grow1, Ryan A Flynn2, Shawn L Chavez3
1Department of Genetics, Stanford University School of Medicine, Stanford, California 94305, USA.
Nature
|April 22, 2015
まとめ
ヒト内生レトロウイルス (HERVK) は,DNA低甲基化とOCT4.4により,人間の発達初期に発現します. RecのようなHERVKタンパク質は,ウイルス感染を抑制し,胚の発達に影響を与えます.
科学分野:
- ゲノミクスゲノミクスとは
- 分子生物学は分子生物学である.
- 発達生物学 発達生物学について
背景:
- 固有のレトロウイルス (ERV) は,ヒトゲノムの8%を占める古代のレトロウイルス配列です.
- 人間内生レトロウイルスK (HERVK) は,タンパク質をコードする遺伝子を無傷のまま保持し,最近獲得されたものです.
- HERVKは典型的には静止されているが,特定の病理および早期発症において活発である.
研究 の 目的:
- 人間の胚形成中にHERVK発現を調節するメカニズムを調査する.
- 初期の発達と宿主防御におけるHERVKタンパク質の機能的役割を決定する.
主な方法:
- DNAメチル化とOCT4 (POU5F1) トランザクティベーションの分析.
- ヒト胚のサンプルにおけるHERVK転写とタンパク質の検出.
- HERVKタンパク質の活性を評価するために,多能細胞系を用いた機能検査.
主要な成果:
- DNAヒポメチル化とOCT4は,ヒト胚形成中にHERVKの発現を相乗的に活性化します.
- HERVKの転写は,8細胞段階から芽細胞発達の過程で起こります.
- HERVKウイルスのような粒子とGagタンパク質は,ヒトの芽細胞に存在します.
- HERVKアクセサリータンパク質 Recは,細胞表面 IFITM1 を強化し,ウイルス感染を抑制する.
- Recは細胞のRNAと相互作用し,リボソームの占有率を調節する.
結論:
- HERVKの発現は,正常なヒト胚形成の過程で制御されるプロセスです.
- HERVKタンパク質は,発達初期に先天的免疫と宿主-病原体相互作用に役割を果たす可能性があります.
- レトロウイルスの要素は,宿主細胞経路と発達過程に影響を与えることができます.
関連する概念動画
Methods of Nuclear Reprogramming
2.3K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.3K
Somatic to iPS Cell Reprogramming
2.9K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.9K
Induced Pluripotent Stem Cells
28.7K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.7K
Induced Pluripotent Stem Cells
6.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
6.3K
Induced Pluripotent Stem Cells
4.1K
4.1K
Non-LTR Retrotransposons
14.1K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
14.1K


